封面
市場調查報告書
商品編碼
1073428

藥物·遺傳基因通知系統的全球市場 - 產業分析,規模,佔有率,成長,趨勢,2022年~2028年的預測

Global Drug and Gene Delivery Systems Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028

出版日期: | 出版商: Value Market Research | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

本報告提供全球藥物·遺傳基因通知系統市場相關調查,提供市場概要,以及各給藥途徑,媒介,手法,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 藥物·遺傳基因通知系統-產業分析

  • 簡介-市場動態
  • 市場促進因素
  • 市場阻礙因素
  • 機會
  • 產業趨勢
  • 波特的五力分析
  • 市場魅力分析

第4章 價值鏈分析

第5章 COVID-19疫情的影響分析

第6章 全球藥物·遺傳基因通知系統的市場分析,各給藥途徑

  • 各給藥途徑概要
  • 履歷資料與預測資料
  • 各給藥途徑分析
  • 口服市場,各地區
  • 吸入市場,各地區
  • 經皮吸收型市場,各地區
  • 注射市場,各地區
  • 眼科市場,各地區
  • 經鼻子市場,各地區
  • 局部市場,各地區

第7章 全球藥物·遺傳基因通知系統的市場分析,各媒介

  • 各媒介概要
  • 履歷資料與預測資料
  • 各媒介分析
  • 病毒市場,各地區
  • 非病毒市場,各地區

第8章 全球藥物·遺傳基因通知系統的市場分析,各手法

  • 各手法概要
  • 履歷資料與預測資料
  • 各手法分析
  • In Situ市場,各地區
  • Ex vivo市場,各地區

第9章 藥物·遺傳基因通知系統的市場分析,各地區

  • 各地區的預測
  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第10章 藥物·遺傳基因通知系統企業的競爭情形

  • 藥物·遺傳基因通知系統市場上競爭
  • 夥伴關係/合作/契約
  • 合併和收購
  • 新產品的銷售
  • 其他的開發

第11章 企業簡介

  • 企業佔有率分析
  • 市場集中度
  • Novartis AG
  • Amgen Inc.
  • Oxford BioMedica plc
  • SIBIONO
  • Becton
  • Dickinson
Product Code: VMR11214683

Value Market Research deeply researched the Global Drug and Gene Delivery Systems Market to foresee a significant growth in the industry over the upcoming years. The global drug and gene delivery systems market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global drug and gene delivery systems market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this drug and gene delivery systems market.

The next sections of the drug and gene delivery systems market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below-

By Route of Administration

Oral

Inhalation

Transdermal

Injectable

Ocular

Nasal

Topical

By Vector

Viral

Non-viral

By Method

In Situ

Ex Vivo

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . DRUG AND GENE DELIVERY SYSTEMS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Route of Administration
    • 3.7.2 By Vector
    • 3.7.3 By Method
    • 3.7.4 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL DRUG AND GENE DELIVERY SYSTEMS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1 Overview by Route of Administration
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Route of Administration
  • 6.4 Oral Market by Regions
  • 6.5 Inhalation Market by Regions
  • 6.6 Transdermal Market by Regions
  • 6.7 Injectable Market by Regions
  • 6.8 Ocular Market by Regions
  • 6.9 Nasal Market by Regions
  • 6.10. Topical Market by Regions

7 . GLOBAL DRUG AND GENE DELIVERY SYSTEMS MARKET ANALYSIS BY VECTOR

  • 7.1 Overview by Vector
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Vector
  • 7.4 Viral Market by Regions
  • 7.5 Non-viral Market by Regions

8 . GLOBAL DRUG AND GENE DELIVERY SYSTEMS MARKET ANALYSIS BY METHOD

  • 8.1 Overview by Method
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Method
  • 8.4 In Situ Market by Regions
  • 8.5 Ex Vivo Market by Regions

9 . GLOBAL DRUG AND GENE DELIVERY SYSTEMS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America
    • 9.3.1. Overview, Historic and Forecast Data
    • 9.3.2. North America By Segment
    • 9.3.3. North America By Country
    • 9.3.4. United State
    • 9.3.5. Canada
    • 9.3.6. Mexico
  • 9.4. Europe
    • 9.4.1. Overview, Historic and Forecast Data
    • 9.4.2. Europe by Segment
    • 9.4.3. Europe by Country
    • 9.4.4. United Kingdom
    • 9.4.5. France
    • 9.4.6. Germany
    • 9.4.7. Italy
    • 9.4.8. Russia
    • 9.4.9. Rest Of Europe
  • 9.5. Asia Pacific
    • 9.5.1. Overview, Historic and Forecast Data
    • 9.5.2. Asia Pacific by Segment
    • 9.5.3. Asia Pacific by Country
    • 9.5.4. China
    • 9.5.5. India
    • 9.5.6. Japan
    • 9.5.7. South Korea
    • 9.5.8. Australia
    • 9.5.9. Rest Of Asia Pacific
  • 9.6. Latin America
    • 9.6.1. Overview, Historic and Forecast Data
    • 9.6.2. Latin America by Segment
    • 9.6.3. Latin America by Country
    • 9.6.4. Brazil
    • 9.6.5. Argentina
    • 9.6.6. Peru
    • 9.6.7. Chile
    • 9.6.8. Rest of Latin America
  • 9.7. Middle East & Africa
    • 9.7.1. Overview, Historic and Forecast Data
    • 9.7.2. Middle East & Africa by Segment
    • 9.7.3. Middle East & Africa by Country
    • 9.7.4. Saudi Arabia
    • 9.7.5. UAE
    • 9.7.6. Israel
    • 9.7.7. South Africa
    • 9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE DRUG AND GENE DELIVERY SYSTEMS COMPANIES

  • 10.1. Drug And Gene Delivery Systems Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF DRUG AND GENE DELIVERY SYSTEMS INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Novartis AG
    • 11.3.1. Company Overview
    • 11.3.2. Financials
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Amgen Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Financials
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Oxford BioMedica plc
    • 11.5.1. Company Overview
    • 11.5.2. Financials
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. SIBIONO
    • 11.6.1. Company Overview
    • 11.6.2. Financials
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Becton
    • 11.7.1. Company Overview
    • 11.7.2. Financials
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Dickinson
    • 11.8.1. Company Overview
    • 11.8.2. Financials
    • 11.8.3. Products
    • 11.8.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Route of Administration (USD MN)
  • Oral Market by Geography (USD MN)
  • Inhalation Market by Geography (USD MN)
  • Transdermal Market by Geography (USD MN)
  • Injectable Market by Geography (USD MN)
  • Ocular Market by Geography (USD MN)
  • Nasal Market by Geography (USD MN)
  • Topical Market by Geography (USD MN)
  • Analysis Market by Vector (USD MN)
  • Viral Market by Geography (USD MN)
  • Non-viral Market by Geography (USD MN)
  • Analysis by Method (USD MN)
  • In Situ Market by Geography (USD MN)
  • Ex Vivo Market by Geography (USD MN)
  • Global Drug And Gene Delivery Systems Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Drug And Gene Delivery Systems Report
  • Market Research Process
  • Market Research Methodology
  • Global Drug And Gene Delivery Systems Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Route of Administration
  • Market Attractiveness Analysis by Vector
  • Market Attractiveness Analysis by Method
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Route of Administration (USD MN)
  • Oral Market by Geography (USD MN)
  • Inhalation Market by Geography (USD MN)
  • Transdermal Market by Geography (USD MN)
  • Injectable Market by Geography (USD MN)
  • Ocular Market by Geography (USD MN)
  • Nasal Market by Geography (USD MN)
  • Topical Market by Geography (USD MN)
  • Global Market Analysis by Vector (USD MN)
  • Viral Market by Geography (USD MN)
  • Non-viral Market by Geography (USD MN)
  • Global Market Analysis by Method (USD MN)
  • In Situ Market by Geography (USD MN)
  • Ex Vivo Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.